Related Experiment Video

Updated: May 11, 2026

Precision Ultrasound-guided Stem Cell Delivery for Vascular Repair in Aortic Diseases
04:59

Precision Ultrasound-guided Stem Cell Delivery for Vascular Repair in Aortic Diseases

Published on: June 20, 2025

The ALK-1/Smad1 pathway in cardiovascular physiopathology. A new target for therapy?

María González-Núñez1, José M Muñoz-Félix, José M López-Novoa

  • 1Department of Physiology and Pharmacology, University of Salamanca, Salamanca, Spain.

Biochimica Et Biophysica Acta
|May 28, 2013
PubMed

Insights

Activin receptor-like kinase-1 (ALK-1) is crucial for cardiovascular homeostasis and remodeling. Its dysregulation is linked to cardiovascular diseases, suggesting therapeutic potential via the ALK-1/Smad-1 pathway.

Area of Science:

  • Cardiovascular Biology
  • Cell Signaling
  • Molecular Medicine

Background:

  • Activin receptor-like kinase-1 (ALK-1) is a TGF-β superfamily receptor primarily studied in endothelial cells and angiogenesis.
  • Emerging evidence suggests ALK-1's broader role in cardiovascular homeostasis beyond endothelial cells, including smooth muscle cells and macrophages.
  • ALK-1 expression and function in various cell types are critical for maintaining cardiovascular health.

Purpose of the Study:

  • To provide a comprehensive overview of ALK-1's multifaceted roles in cardiovascular homeostasis.
  • To elucidate the involvement of ALK-1 in the pathogenesis of diverse cardiovascular diseases.
  • To explore the therapeutic potential of targeting the ALK-1/Smad-1 pathway.

Main Methods:

  • Literature review synthesizing existing research on ALK-1.
  • Analysis of genetic studies in animal models and human patients with ALK-1 mutations.
  • Examination of ALK-1 expression patterns in various cardiovascular cell types and disease states.

Main Results:

  • ALK-1 deficiency is associated with Hereditary Hemorrhagic Telangiectasia and pulmonary hypertension.
  • Increased ALK-1 levels in atherosclerotic plaques suggest a protective role.
  • ALK-1 regulates cell proliferation, migration, and extracellular matrix modulation, impacting cardiovascular remodeling.

Conclusions:

  • ALK-1 plays a significant role in cardiovascular homeostasis and disease development.
  • Targeting the ALK-1/Smad-1 pathway presents a promising therapeutic strategy for cardiovascular conditions.
  • Further research into ALK-1's non-endothelial functions is warranted for comprehensive understanding.
Keywords:
AngiogenesisArteriovenous malformationHHTPulmonary hypertensionSmadsTGF-β

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...